Archive | Cancer in the News

FDA grants orphan drug designation to pIL-12 for unresectable melanoma

The FDA granted orphan drug designation to tavokinogene telsaplasmid for the treatment of unresectable metastatic melanoma, according to the agent’s manufacturer.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for May 2017

Whole-genome landscapes of major melanoma subtypes

Read the full story

Posted in Journal Articles

Melanoma Journal Articles for April 2017

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.

Read the full story

Posted in Journal Articles

FDA fast tracks ocular melanoma treatment

A new class of treatment that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.

Read the full story

Posted in Melanoma In The News, FDA, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories